[Patients treated for gynecologic cancer after use of oral contraceptives and IUD].
D000328:Adult; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D005833:Genital Neoplasms, Female / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D008234:Lynestrenol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009367:Neoplasm Staging; D009641:Norethynodrel / Q000009:adverse effects
D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D008656:Mestranol; D008234:Lynestrenol
Fogamzásgátló szerek (OFG) és eszközök (IUD) használata után kezelt nögyógyászati carcinomás betegeink.